Company: MDCXW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001062993-25-016838
Chunk: 19

Company: Medicus Pharma Ltd.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 19
---
) -   (383,823) (583,823) -  (583,823)Loss on extinguishment of debentures (25,000) -   (25,000) (25,000) -  (25,000)Total other income (expense)  (554,972) 55,514  (610,486) (691,102) (23,511) (667,591)Net loss for the period (15,981,312) (2,278,747) (13,702,565) (27,259,804) (7,618,964) (19,640,840)Deemed dividend on warrant inducement (4,954,518) -  (4,954,518) (4,954,518) -  (4,954,518)Net loss for the period attributable to common shareholders (20,935,830) (2,278,747) (18,657,083) (32,214,322) (7,618,964) (24,595,358)Foreign currency translation adjustment 10,828  -  10,828  10,828  -  10,828 Comprehensive loss for the period (20,925,002) (2,278,747) (18,646,255) (32,203,494) (7,618,964) (24,584,530)Net loss per common share (basic and diluted) (1.12) (0.24)    (1.91) (0.84)   

23

General and administrative

  Three months endedSeptember 30,     Nine months endedSeptember 30,      2025  2024     2025  2024      $  $  Change   $  $  Change Professional fees 480,376  462,068  18,308  3,785,413  1,521,410  2,264,003 Consulting fees 1,339,341  417,405  921,936  2,007,557  1,356